AVR 3.21% $11.76 anteris technologies ltd

buyers v sellers, page-55

  1. 8,406 Posts.
    lightbulb Created with Sketch. 257
    "Completion of trial results is now well past its use-by date so that says to me some drama has been encountered along the way?"...

    may equally be that there are no dramas and that the results need to reviewed several times by independent bodies which takes time,,,,timo....o simply assert that the market " is discounting the possibility of any sparkling results of vaccine trials"....again..who knows? as usual supposition based on more supposition. Give me more quality argument and research anytime.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.